You are here

  • Home
  • Archive
  • Volume 10, Issue 2
  • Addition of peak flow monitoring to symptom monitoring did not improve healthcare visits, quality of life, or lung function in older adults with moderate-to-severe asthma

Article Text

Article menu
Download PDFPDF
Treatment
Addition of peak flow monitoring to symptom monitoring did not improve healthcare visits, quality of life, or lung function in older adults with moderate-to-severe asthma

https://doi.org/10.1136/ebn.10.2.52

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Buist AS, Vollmer WM, Wilson SR, et al. A randomized clinical trial of peak flow versus symptom monitoring in older adults with asthma. Am J Respir Crit Care Med 2006;174:1077–87.OpenUrlCrossRefPubMed

    Q In older adults with moderate-to-severe asthma, is symptom monitoring plus peak flow monitoring (PFM) (used as part of a comprehensive management plan) better than symptom monitoring alone for healthcare utilisation, quality of life, and lung function?

    METHODS

    Embedded ImageDesign:

    randomised controlled trial.

    Embedded ImageAllocation:

    {concealed}.*

    Embedded ImageBlinding:

    blinded (data collectors and {healthcare providers}*).

    Embedded ImageFollow up period:

    up to 2 years.

    Embedded ImageSetting:

    a large managed care organisation in Oregon, USA.

    Embedded ImagePatients:

    296 adults 50–92 years of age (mean age 66 y, 52% women) who had physician diagnosed asthma, medication use suggestive of moderate-to-severe asthma, bronchodilator reversibility (>8% of baseline forced expiratory volume in 1 sec [FEV1 …

    View Full Text

    Footnotes

    • ↵* Information provided by author.

    • For correspondence: Dr A S Buist, Oregon Health and Science University, Portland, OR, USA. buists{at}ohsu.edu

    • Source of funding: National Heart, Lung, and Blood Institute.